What is IDN's health score?

Intellicheck, Inc. (IDN) has a TradeApes health score of 60 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is IDN's estimated fair value?

Based on our 5-year discounted cash flow model, Intellicheck, Inc.'s estimated fair value is $3.38 per share, representing a -9.3% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is IDN undervalued or overvalued?

Our model currently rates IDN as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

3 free score cards remaining

Intellicheck, Inc. (IDN)

Technology Fair Value low healthy

$3.73

Updated: 2026-07-18

TradeApes Score

Financial Strength

85 Strong

Operating Trend

76 Strong

Relative Value

30 Weak

Capital Allocation

30 Weak

Risk Management

80 Strong

Est. Fair Value $3.38

DCF Upside -9.3%

Sector Rank #1472 of 15020

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Extreme P/E — above 45×, very high expectations embedded in price

Unlock Full Report →

Industry Related Stocks

ACI WORLDWIDE, INC. (ACIW) ADOBE INC. (ADBE) Autodesk, Inc. (ADSK) AUDIOEYE INC (AEYE) C3.ai, Inc. (AI) FIREFLY NEUROSCIENCE, INC. (AIFF)

See all Technology stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.